ENCORAFENIB for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 2,591 adverse event reports in the FDA FAERS database where ENCORAFENIB was used for Malignant melanoma.
Most Reported Side Effects for ENCORAFENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 1,004 | 11.7% | 989 | 60 |
| Off label use | 989 | 11.6% | 165 | 186 |
| Nausea | 758 | 8.9% | 38 | 213 |
| Fatigue | 685 | 8.0% | 54 | 167 |
| Diarrhoea | 574 | 6.7% | 37 | 221 |
| Neoplasm progression | 548 | 6.4% | 163 | 107 |
| Pyrexia | 539 | 6.3% | 34 | 241 |
| Product use in unapproved indication | 506 | 5.9% | 77 | 63 |
| Vomiting | 429 | 5.0% | 24 | 173 |
| Rash | 414 | 4.8% | 22 | 83 |
| Serous retinal detachment | 297 | 3.5% | 13 | 56 |
| Arthralgia | 281 | 3.3% | 13 | 56 |
| Malaise | 266 | 3.1% | 30 | 85 |
| Decreased appetite | 261 | 3.1% | 32 | 111 |
| Asthenia | 213 | 2.5% | 29 | 85 |
Other Indications for ENCORAFENIB
Colon cancer (1,294)
Metastatic malignant melanoma (865)
Colorectal cancer metastatic (362)
Colorectal cancer (289)
Product used for unknown indication (241)
Neoplasm malignant (199)
Metastasis (168)
Colon cancer metastatic (134)
Thyroid cancer (115)
Rectal cancer (100)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)
TALIMOGENE LAHERPAREPVEC (562)